by Nisha Cooch, PhD | Jan 28, 2019 | Genetic Counselor Resource Page One, Genetic Counselor Resource Pages, Neurologists Resource Page One, Neurologists Resource Pages, Nursing Resource Page One, Nursing Resource Pages, Nutritionist Resource Page One, Nutritionist Resource Pages, Orthopedics Resource Page One, Orthopedics Resource Pages, Pediatricians Resource Page One, Pediatricians Resources, Physical Therapists Resource Page One, Physical Therapists Resource Pages, Pulmonologist Resource Page One, Pulmonologist Resource Pages, Radiology Resource Page One, Radiology Resources, Social Worker Resource Page One, Social Worker Resource Pages, Urologist Resource Page One, Urologist Resources
At the end of 2016, the U.S. Food and Drug Administration (FDA) approved nusinersen for the treatment of spinal muscular atrophy (SMA).1 Because of the high threshold for FDA approval, an abundance of data on nusinersen and its physiological effects on SMA patients...
by BNS Staff | Oct 8, 2018 | Pediatricians Resource Page One, Pediatricians Resources, Urologist Resource Page One, Urologist Resources
Involuntary wetting is one of the most common problems of childhood. One in 10 seven year-old children, for example, experience bedwetting, and about 6% of seven-year-olds wet themselves during the day.1 There is evidence to suggest, however, that the rate of enuresis...
by BNS Staff | Sep 4, 2018 | Urologist Resource Page One, Urologist Resources
Spinal Muscular Atrophy (SMA) is a congenital motor neuron degenerative disorder resulting in weakness, low tone, and when presenting in early life, death.1 Though some investigators have seen evidence of sensory nerve death,2 SMA is typically considered to be a motor...
